XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022   109,871      
Beginning balance at Dec. 31, 2022 $ 324,506 $ 110 $ 2,380,651 $ (2,046,569) $ (9,686)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 153     153  
Other comprehensive income (loss), net of tax (2,492)       (2,492)
Issuance of common stock under stock option, award and purchase plans, net (in shares)   2,300      
Issuance of common stock under stock option, award and purchase plans, net (2,091) $ 2 (2,093)    
Stock-based compensation $ 20,724   20,724    
Issuance of common stock upon conversion of 2024 Notes (in shares) 0        
Ending balance (in shares) at Sep. 29, 2023   112,171      
Ending balance at Sep. 29, 2023 $ 340,800 $ 112 2,399,282 (2,046,416) (12,178)
Beginning balance (in shares) at Jun. 30, 2023   111,584      
Beginning balance at Jun. 30, 2023 342,801 $ 112 2,389,573 (2,039,921) (6,963)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (6,495)     (6,495)  
Other comprehensive income (loss), net of tax (5,215)       (5,215)
Issuance of common stock under stock option, award and purchase plans, net (in shares)   587      
Issuance of common stock under stock option, award and purchase plans, net 2,468   2,468    
Stock-based compensation 7,241   7,241    
Ending balance (in shares) at Sep. 29, 2023   112,171      
Ending balance at Sep. 29, 2023 $ 340,800 $ 112 2,399,282 (2,046,416) (12,178)
Beginning balance (in shares) at Dec. 31, 2023 112,407 112,407      
Beginning balance at Dec. 31, 2023 $ 436,874 $ 112 2,405,043 (1,962,575) (5,706)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 1,097     1,097  
Other comprehensive income (loss), net of tax 1,819       1,819
Issuance of common stock under stock option, award and purchase plans, net (in shares)   1,935      
Issuance of common stock under stock option, award and purchase plans, net $ (249) $ 2 (251)    
Repurchase of common stock (in shares) (2,400) (2,409)      
Repurchase of common stock $ (30,049) $ (2)   (30,047)  
Excise tax on share repurchases (90)     (90)  
Stock-based compensation $ 19,587   19,587    
Issuance of common stock upon conversion of 2024 Notes (in shares) 4,578 4,578      
Issuance of common stock upon conversion of 2024 Notes $ (52) $ 5 (57)    
Ending balance (in shares) at Sep. 27, 2024 116,511 116,511      
Ending balance at Sep. 27, 2024 $ 428,937 $ 117 2,424,322 (1,991,615) (3,887)
Beginning balance (in shares) at Jun. 28, 2024   115,998      
Beginning balance at Jun. 28, 2024 392,808 $ 116 2,416,152 (2,013,333) (10,127)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 21,718     21,718  
Other comprehensive income (loss), net of tax 6,240       6,240
Issuance of common stock under stock option, award and purchase plans, net (in shares)   513      
Issuance of common stock under stock option, award and purchase plans, net 2,461 $ 1 2,460    
Stock-based compensation $ 5,710   5,710    
Ending balance (in shares) at Sep. 27, 2024 116,511 116,511      
Ending balance at Sep. 27, 2024 $ 428,937 $ 117 $ 2,424,322 $ (1,991,615) $ (3,887)